248 - Infectious Endocarditis Hot Topics

Saturday, October 19, 2024

1:45 PM – 3:00 PM US PT

Location: 502 B

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Senu Apewokin, MD

Assoc Prof
University of Cincinnati
Mason, OH, United States
Molly Paras, MD

Assistant Professor, Harvard Medical School
Massachusetts General Hospital

Faculty(s)

MS

Michael Sekela, MD

Division Chief CT Surgery
University of Kentucky Medical Center
Lexington, KY, United States
LM

Laura Marks, MD, PhD

Infectious Diseases Fellow
Washington University in St. Louis
St Louis, Missouri, United States

Disclosure(s):

Senu Apewokin, MD: Nestle/Seres: Stocks/Bonds (Public Company) (Terminated, June 30, 2023); Speakers Bureau for Nestle Health Science: Honoraria (Ongoing)

Molly Paras, MD: No financial relationships to disclose

Michael E. Sekela, MD: Edwards Scientific: Advisor/Consultant (Ongoing)

Laura R. Marks, MD, PhD: Gilead FOCUS: Grant/Research Support (Ongoing)

Learning Objectives:

At the conclusion of this session, participants will be able to:

analyze new developments in the diagnosis of ie: new tools and recently proposed duke criteria modifications;
identify indications for surgery and angiovac use in the treatment of ie;
describe available data on antibiotic treatment for ivdu-associated ie.

Presentations:

1:45 PM – 2:10 PM US PT

Update on IE diagnosis
Speaker: Molly Paras, MD – Massachusetts General Hospital
2:10 PM – 2:35 PM US PT

Percutaneous Mechanical Aspiration or Surgical Resection
Speaker: Michael E. Sekela, MD – University of Kentucky Medical Center
2:35 PM – 3:00 PM US PT

IVDU-associated IE antibiotic treatment
Speaker: Laura R. Marks, MD, PhD – Washington University in St. Louis